Clinical trial
TNFalfa Blocking Treatment of Spondylarthropathies
NCT00133315 · Hvidovre University Hospital, Other · Completed
Key facts
| NCT number | NCT00133315 |
|---|---|
| Title | TNFalfa Blocking Treatment of Spondylarthropathies |
| Official title | TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies |
| Lead sponsor | Hvidovre University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Spondylarthropathies, Ankylosing Spondylitis, Psoriatic Arthritis |
| Intervention type | Drug |
| Interventions | Infliximab, Etanercept, Adalimumab |
| Enrollment | 50 |
| Start date | Sep 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Aug 23, 2005 |
| Last update posted | Apr 10, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: